Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI eye on your gut: could Computer-Aided colonoscopy cut cancer risk?

NCT ID NCT07299071

Prevention Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a computer-aided detection (CADe) system during screening colonoscopy helps find and remove more advanced polyps, potentially lowering the risk of colorectal cancer. About 592 adults at increased risk for colorectal cancer will be randomly assigned to standard colonoscopy or colonoscopy with CADe. Researchers will then check after 3 years to see if fewer advanced adenomas developed in the CADe group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
computer-aided detection (CADe) system
What this could lead to
If successful, this could show that using AI during colonoscopy helps prevent advanced polyps and potentially reduces the risk of colorectal cancer.
What could go wrong
This is a relatively small, early-stage trial (592 participants) and the benefit of CADe in reducing long-term cancer risk is still unproven. The AI may also have false positives or miss some lesions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 592 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Mar 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 18 years of age with indication for colonoscopy as part of a screening program, after a positive immunological (FIT) test, and/or for personal or family history of colorectal cancer and/or personal history of colonic adenomas, * Written informed consent signed * Patients covered by a health-care insurance. Exclusion Criteria: * Failed complete colonoscopy, defined by the absence of cecal intubation and/or the absence of terminal ileum cauterization * Inadequate bowel preparation (Boston bowel preparation score \< 6, and/or least at one part of colon with score ≤ 1) * An infiltrative tumor was diagnosed during colonoscope insertion time, not accessible to endoscopic resection and likely to require surgical management (a procedure where part of the colon may need to be removed). * Patient under guardianship or protection * Pregnant women * Not fluent in French or illiterate * Personal history of inflammatory bowel disease * Personal history of genetic predisposition of CRC * Personal history of colonic surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colonoscopy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal neoplasm intestinal polyp colorectal adenoma prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colonoscopy Colorectal neoplasms Intestinal polyps

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • APHP - Hôpital Saint Antoine

    NOT_YET_RECRUITING

    Paris, 75012, France

  • Aphp-Hegp

    NOT_YET_RECRUITING

    Paris, 75015, France

  • CH de la Côte Basque

    NOT_YET_RECRUITING

    Bayonne, 64100, France

  • CHRU de Nancy - Hôpital Brabois Adultes

    NOT_YET_RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • CHU Bordeaux - Hôpital Haut Lévêque

    RECRUITING

    Pessac, 33604, France

  • CHU Brest la Cavale Blanche

    NOT_YET_RECRUITING

    Brest, 29200, France

  • CHU Nîmes

    NOT_YET_RECRUITING

    Nîmes, 30029, France

  • CHU de Limoges

    NOT_YET_RECRUITING

    Limoges, 87042, France

  • CHU de Rennes

    NOT_YET_RECRUITING

    Rennes, 35000, France

  • Clinique Jules Verne

    NOT_YET_RECRUITING

    Nantes, 44300, France

  • Clinique Paris Bercy

    NOT_YET_RECRUITING

    Charenton-le-Pont, 94220, France

  • Clinique Pasteur

    NOT_YET_RECRUITING

    Toulouse, 31076, France

  • Institut Paoli Calmettes

    NOT_YET_RECRUITING

    Marseille, 13009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.